Comparison of Two Conventional Glass Ionomer Cements in the Restoration of Posterior Class II Lesion in the Primary Dentition: a Randomized Controlled Non Inferiority Trial.

Předmět:
Zdroj: Clinical Trials Week; 8/14/2023, p428-428, 1p
Abstrakt: Biomedical, Biomedicine, Biotechnology, Clinical Research, Clinical Trials and Studies, Dental Caries, Dental Cavities, Dental Materials - Ionomer Cement, Dentistry, Health and Medicine, Ionomer Cement, Medical Devices, Oral Hygiene, Dental Materials Keywords: Biomedical; Biomedicine; Biotechnology; Clinical Research; Clinical Trials and Studies; Dental Caries; Dental Cavities; Dental Materials; Dental Materials - Ionomer Cement; Dentistry; Health and Medicine; Ionomer Cement; Medical Devices; Oral Hygiene EN Biomedical Biomedicine Biotechnology Clinical Research Clinical Trials and Studies Dental Caries Dental Cavities Dental Materials Dental Materials - Ionomer Cement Dentistry Health and Medicine Ionomer Cement Medical Devices Oral Hygiene 428 428 1 08/14/23 20230814 NES 230814 2023 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Staff editors report on the newly launched clinical trial, NCT05965297, which has the following summary description: "This study will investigate the clinical performance of a novel restorative glass ionomer (DeltaFil, DMG) in comparison to an established restorative glass ionomer (Riva Self Cure HV, SDI) in the restoration of Class II cavities in primary molars.". [Extracted from the article]
Databáze: Complementary Index